Trial Profile
The study for the efficacy of the combine therapy with proton pump inhibitor and rebamipide for the post-endoscopic submucosal dissection gastric ulcer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Rebamipide (Primary)
- Indications Gastric ulcer
- Focus Pharmacogenomic; Therapeutic Use
- 06 Mar 2012 New trial record